Posted in | News | Business

Alcoa Invest in Mining Giant

Alcoa today announced it is exiting the Shining Prospect special purpose vehicle formed together with Chinalco to purchase shares in Rio Tinto plc. Alcoa will receive a total of $1.021 billion in cash payable in three installments over a six-month period ending July 31, 2009. Alcoa also will receive its pro rata portion of dividends paid by Rio Tinto to date since the investment was made as and when recovered by Shining Prospect.

This transaction will improve Alcoa’s cash position and result in a positive impact on the Company’s debt-to-capital ratio. The Company will record a non-cash after-tax loss of approximately $120 million on the investment in the first quarter of 2009.

“This transaction, combined with our intention to explore opportunities to expand our commercial relationship, strengthens Alcoa’s ability to weather the economic downturn,” said Klaus Kleinfeld, Alcoa President and CEO. “When the global economy recovers, the pent-up consumer and industrial demand will create a broad array of opportunities in both developed and developing regions for Chinalco and Alcoa.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Alcoa - Aluminum Company of America. (2019, February 10). Alcoa Invest in Mining Giant. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=15604.

  • MLA

    Alcoa - Aluminum Company of America. "Alcoa Invest in Mining Giant". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=15604>.

  • Chicago

    Alcoa - Aluminum Company of America. "Alcoa Invest in Mining Giant". AZoM. https://www.azom.com/news.aspx?newsID=15604. (accessed November 21, 2024).

  • Harvard

    Alcoa - Aluminum Company of America. 2019. Alcoa Invest in Mining Giant. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=15604.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.